Reveals that CK2 is essential for promoting mitochondrial fusion in a Wnt/β-catenin-dependent manner, and suggests pharmacologically targeted CK2 for the treatment of ischemic stroke treatment strategies, and is associated with an aberrant increase in gene hypertranscriptional grade MTFP1 for MFN. The gene discussed is MTFP1; the disease is ischemic stroke.